投稿についてもっと詳しく Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment
Shionogi Cilcare agreement

Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment

Montpellier and Osaka – June 6th, 2024 – Cilcare, a leading biotech company specializing in auditory sciences, is pleased to announce a landmark agreement with Shionogi, an impact-driven pharmaceutical company.…

続きを読むCilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment